Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
Aminoglycoside; protein translation inhibitor.<...
Endogenous peptide hormone, counteracts insulin...
Mycotoxin produced by Penicillum and Aspergillu...
mTORC1 inhibitor.
Cysteine-ITC conjugate.
Endogenous quaternary ammonium, required for fa...
DAT inhibitor.
5-Lipoxygenase inhibitor.
Benzimidazole; microtubule polymerization inhib...
STING antagonist
Flavonoid found in various plant sources; matri...
Imidazoline derivative; α1-adrenergic agonist,...
Amino sugar, sorbitol derivative, used as a bul...
Inhibits NS5A
Endogenous hormone and neurotransmitter involve...
Selective and reversible JAK inhibitor.
NSAID; COX-1/2 inhibitor.
Quinoline; PDE 3B inhibitor.
SERCA inhibitor.
Peptide, oxytocin-vasopressin analog.